<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://acurapharm.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.7.3" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.3" -->
<!-- generated-on="July 14, 2014 2:01 pm" -->
<!-- Debug: Total comment count: 0 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://acurapharm.com/</loc>
		<lastmod>2014-04-21T13:54:43+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
	<url>
		<loc>http://acurapharm.com/investors/risk-factors/</loc>
		<lastmod>2014-06-27T19:14:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/oxecta/</loc>
		<lastmod>2014-04-22T13:48:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/partnerships/</loc>
		<lastmod>2014-04-22T13:39:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/productpipeline/</loc>
		<lastmod>2014-04-21T14:44:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/patents/</loc>
		<lastmod>2014-04-21T14:22:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/market-opportunity/</loc>
		<lastmod>2014-04-21T14:01:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/technology-platforms/</loc>
		<lastmod>2014-04-21T13:59:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/</loc>
		<lastmod>2014-04-21T13:57:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/important-safety-info/</loc>
		<lastmod>2013-12-04T16:25:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/nexafed/</loc>
		<lastmod>2013-10-29T20:20:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/business-development/</loc>
		<lastmod>2013-03-08T20:46:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/impede-technology/</loc>
		<lastmod>2013-03-08T17:58:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/need-for-abuse-deterrent-products/</loc>
		<lastmod>2012-09-28T15:41:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/otherproductsindevelopment/</loc>
		<lastmod>2012-09-28T15:38:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/contacts/</loc>
		<lastmod>2012-09-25T20:47:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/aversion-technology/</loc>
		<lastmod>2012-09-25T16:02:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/404-2/</loc>
		<lastmod>2012-09-24T17:48:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/terms-of-use-and-privacy/</loc>
		<lastmod>2012-09-23T01:41:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/medical-meeting-calendar/</loc>
		<lastmod>2012-09-22T20:31:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/advocacy/</loc>
		<lastmod>2012-09-22T20:29:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/</loc>
		<lastmod>2012-09-04T20:24:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/presentations-webcasts/</loc>
		<lastmod>2012-09-04T20:23:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/sec-filings/</loc>
		<lastmod>2012-08-17T15:01:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/vycavert-tablets/</loc>
		<lastmod>2012-07-31T15:04:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/</loc>
		<lastmod>2012-07-31T14:58:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acuracet-tablets/</loc>
		<lastmod>2012-07-31T13:12:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/forward-looking-statement/</loc>
		<lastmod>2012-06-20T20:29:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/about-acura/</loc>
		<lastmod>2012-06-20T19:58:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/terms-of-use/</loc>
		<lastmod>2012-06-08T20:25:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/privacy-policy/</loc>
		<lastmod>2012-06-08T20:23:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/home/</loc>
		<lastmod>2012-05-03T19:08:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/aversion-technology/nasal-snorting/</loc>
		<lastmod>2012-03-20T21:35:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/aversion-technology/intravenous-injection/</loc>
		<lastmod>2012-03-20T21:34:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/facilities/</loc>
		<lastmod>2012-01-19T16:56:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/syringeability-testing/</loc>
		<lastmod>2011-10-21T15:52:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/extraction-testing/</loc>
		<lastmod>2011-10-21T15:50:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-105/</loc>
		<lastmod>2011-10-21T15:47:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-114/</loc>
		<lastmod>2011-10-21T15:46:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-111/</loc>
		<lastmod>2011-10-21T15:44:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-102/</loc>
		<lastmod>2011-10-21T15:41:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-107/</loc>
		<lastmod>2011-10-21T15:40:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-103/</loc>
		<lastmod>2011-10-21T15:38:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-106/</loc>
		<lastmod>2011-10-21T15:36:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-109/</loc>
		<lastmod>2011-10-21T15:35:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-108/</loc>
		<lastmod>2011-10-21T15:34:49+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-104/</loc>
		<lastmod>2011-10-21T15:33:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/study-ap-adf-101/</loc>
		<lastmod>2011-10-21T15:31:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/products/acurox-tablets/</loc>
		<lastmod>2011-10-21T15:27:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/our-business/management/</loc>
		<lastmod>2011-10-03T20:17:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/board-of-directors/</loc>
		<lastmod>2011-08-01T17:13:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/platforms/aversion-technology/intentional-swallowing/</loc>
		<lastmod>2011-08-01T15:54:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/public-filings/</loc>
		<lastmod>2011-06-08T14:22:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/compensation-committee-charter/</loc>
		<lastmod>2009-07-08T19:22:10+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/</loc>
		<lastmod>2009-06-22T17:33:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/audit-committee-charter/</loc>
		<lastmod>2009-06-21T20:45:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/corporate/code-of-ethics/</loc>
		<lastmod>2009-06-21T17:36:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://acurapharm.com/investors/stock-price/</loc>
		<lastmod>2009-06-20T21:31:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>